Plaque Essay
VIRAL QUANTIFICATION USING A PLAQUE ASSAY
Doctors prescribing antivirals for chronic infections need to continuously monitor the severity of the infection. They do this by determining the concentration of viral particles in a given sample. This value is often referred to as the viral load, the viral burden, or the viral titer. Knowing their viral load helps patients better manage their condition and make decisions about activities that could potentially spread an active virus.
There are many methods for measuring viral load. One highly accurate method is to measure the number of specific viral DNA or RNA sequences in a sample using either quantitative PCR or reverse transcriptase PCR. This method requires access to both advanced equipment and highly trained technicians. Another popular tool is the Enzyme-linked Immunosorbent Assay (ELISA), which uses antibody-antigen binding to detect specific antiviral proteins in a patient's sample. ELISAs are quick and sensitive but are only indirect measures of viral load. Finally, a plaque assay can be used to determine viral load based on the number of cells infected by active viruses in a patient’s sample.
During a plaque assay, the potentially infected sample is serially diluted and inoculated into a host cell culture. This is followed by an incubation period that allows any virions present to attach to these new cells. Next, a layer of agar is poured over the potentially infected cells. Because the host cell culture is a single layer of cells and because the agar blocks the virus from moving vertically the only way for a virus to spread is by infecting a neighboring cell. Consequently, during the next incubation period, a circular zone of infection will form around any cell that was infected. This circular zone is known as a plaque and can, in fact, be visualized by the naked eye – particularly when additional dyes that emphasize the difference between uninfected, living cells and infected, dead cells are used.
During a plaque assay, the viral load is calculated as a measure of plaque forming unit (PFU) per milliliter. To account for variation and errors in counting, only plates containing between 10 and 100 plaques are used to calculated PFU measurements. In addition, multiple plates are prepared per sample because the viral concentration in a patient can vary tremendously over time. For example, someone who has recently been infected with HIV can have over 40 million viral copies per mL of blood while someone on treatment with an undetectable viral load can have less than 50 viral copies per mL. To account for this range scientists will prepare a serial dilution of the initial sample, create a plate for each dilution, and then incorporate the dilution strength into their PFU calculations.
Viral Quantification Steps for Lab
Summary - Dengue Defense Project
The Dengue Defense Project studies the effectiveness of two potential anti-dengue fever medications that have recently been approved for testing in humans. Measurement of viral load, using a laboratory technique called a plaque assay, will be used to evaluate the effectiveness of each medication over time. Plaque assays monitor the movement of viruses into cells on agar plates in the lab.
Take detailed notes on each step of the Plaque Essay
Measuring Viral Load
Labeling Plates
Infected Cells
Incubate
Plaques
Counting Plaques
For the viral quantification experiment, blood samples were taken from two patients newly infected with dengue fever, before and during treatment with an antiviral medication. You are responsible for preparing four plaque assay plates at different concentrations to determine the viral load of one patient at one time point. At the lab, you will pool data with other teams to share results and evaluate the effectiveness of each treatment.